Stock Track | Privia Health (PRVA) Soars 5.06% Pre-market on Q2 Earnings Beat and Raised Guidance

Stock Track

Aug 07, 2025

Privia Health Group, Inc. (NASDAQ: PRVA) saw its stock surge 5.06% in pre-market trading on Thursday following the release of its second-quarter 2025 financial results. The healthcare company significantly outperformed earnings expectations and raised its full-year guidance, signaling strong growth and improved profitability.

Privia Health reported adjusted earnings per share of $0.24 for Q2, beating the analyst consensus estimate of $0.05 by an impressive 380%. This represents a 26.32% increase from the same period last year. While the company's quarterly revenue of $521.2 million missed the estimate of $800.1 million, it still showed a robust 23.4% year-over-year growth.

The company's strong performance was evident across key metrics. Implemented providers increased by 13.8% compared to Q2 2024, reaching 5,125. Value-based care attributed lives grew by 15.2% to 1,382,000, and practice collections surged 18.5% to $862.9 million. Notably, Privia Health raised its full-year 2025 guidance to above the high end of the previous range for practice collections, GAAP revenue, platform contribution, and adjusted EBITDA, reflecting management's confidence in continued growth and operational efficiency.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1197071672"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1197071672\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1197071672?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-07 18:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1197071672","market":"us","top_or_hot":-1,"title":"Stock Track | Privia Health (PRVA) Soars 5.06% Pre-market on Q2 Earnings Beat and Raised Guidance","media":"Stock Track","content":"<p>Privia Health Group, Inc. (NASDAQ: PRVA) saw its stock surge 5.06% in pre-market trading on Thursday following the release of its second-quarter 2025 financial results. The healthcare company significantly outperformed earnings expectations and raised its full-year guidance, signaling strong growth and improved profitability.</p>\n\n<p>Privia Health reported adjusted earnings per share of $0.24 for Q2, beating the analyst consensus estimate of $0.05 by an impressive 380%. This represents a 26.32% increase from the same period last year. While the company's quarterly revenue of $521.2 million missed the estimate of $800.1 million, it still showed a robust 23.4% year-over-year growth.</p>\n\n<p>The company's strong performance was evident across key metrics. Implemented providers increased by 13.8% compared to Q2 2024, reaching 5,125. Value-based care attributed lives grew by 15.2% to 1,382,000, and practice collections surged 18.5% to $862.9 million. Notably, Privia Health raised its full-year 2025 guidance to above the high end of the previous range for practice collections, GAAP revenue, platform contribution, and adjusted EBITDA, reflecting management's confidence in continued growth and operational efficiency.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Privia Health (PRVA) Soars 5.06% Pre-market on Q2 Earnings Beat and Raised Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Privia Health (PRVA) Soars 5.06% Pre-market on Q2 Earnings Beat and Raised Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-08-07 18:38</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Privia Health Group, Inc. (NASDAQ: PRVA) saw its stock surge 5.06% in pre-market trading on Thursday following the release of its second-quarter 2025 financial results. The healthcare company significantly outperformed earnings expectations and raised its full-year guidance, signaling strong growth and improved profitability.</p>\n\n<p>Privia Health reported adjusted earnings per share of $0.24 for Q2, beating the analyst consensus estimate of $0.05 by an impressive 380%. This represents a 26.32% increase from the same period last year. While the company's quarterly revenue of $521.2 million missed the estimate of $800.1 million, it still showed a robust 23.4% year-over-year growth.</p>\n\n<p>The company's strong performance was evident across key metrics. Implemented providers increased by 13.8% compared to Q2 2024, reaching 5,125. Value-based care attributed lives grew by 15.2% to 1,382,000, and practice collections surged 18.5% to $862.9 million. Notably, Privia Health raised its full-year 2025 guidance to above the high end of the previous range for practice collections, GAAP revenue, platform contribution, and adjusted EBITDA, reflecting management's confidence in continued growth and operational efficiency.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PRVA","symbol_name":"Privia Health Group, Inc.","start_time":0,"source_url":"","article_id":"1197071672","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1197071672","pubTimestamp":1754563120,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Privia Health Group, Inc. (NASDAQ: PRVA) saw its stock surge 5.06% in pre-market trading on Thursday following the release of its second-quarter 2025 financial results. The healthcare company...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"PRVA":"Privia Health Group, Inc."},"translate_title":"股票追踪|Privia Health(PRVA)因第二季度盈利超出预期并上调指引而盘前飙升5.06%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PRVA":1},"content_text":"Privia Health Group, Inc. (NASDAQ: PRVA) saw its stock surge 5.06% in pre-market trading on Thursday following the release of its second-quarter 2025 financial results. The healthcare company significantly outperformed earnings expectations and raised its full-year guidance, signaling strong growth and improved profitability.\nPrivia Health reported adjusted earnings per share of $0.24 for Q2, beating the analyst consensus estimate of $0.05 by an impressive 380%. This represents a 26.32% increase from the same period last year. While the company's quarterly revenue of $521.2 million missed the estimate of $800.1 million, it still showed a robust 23.4% year-over-year growth.\nThe company's strong performance was evident across key metrics. Implemented providers increased by 13.8% compared to Q2 2024, reaching 5,125. Value-based care attributed lives grew by 15.2% to 1,382,000, and practice collections surged 18.5% to $862.9 million. Notably, Privia Health raised its full-year 2025 guidance to above the high end of the previous range for practice collections, GAAP revenue, platform contribution, and adjusted EBITDA, reflecting management's confidence in continued growth and operational efficiency.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}